1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailly, C; Bourgeois, M; Bris, NL; Chérel, M; Faivre-Chauvet, A; Le Bihan, T; Le Saëc, P; Navarro, AS; Saï-Maurel, C; Tripier, R | 1 |
1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Multiple Myeloma
Article | Year |
---|---|
TE1PA as Innovating Chelator for
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Heterocyclic Compounds, 1-Ring; Immunoconjugates; Mice; Multiple Myeloma; Positron-Emission Tomography; Tissue Distribution | 2019 |